Literature DB >> 28197252

Squamous Cell Carcinoma of Lung Atypically Involving Heart: A Case Report With Literature Review.

Tony Ete1, Pravin Jha2, Bhupen Barman1, Animesh Mishra2, Manish Kapoor2, Amit Malviya2, Vandana Raphael3, Neel Kanth Issar1.   

Abstract

Cardiac metastasis usually appears in patients with disseminated tumor disease. Involvement of heart in malignancy is generally underestimated and found to be in up to 25% of post mortem patients who had died of cancer. Cardiac involvement in metastases is usually uncommon; however, it may present with tachycardia, arrhythmia, cardiomegaly, heart failure, dyspnoea, hypotension, and pulsus paradoxus. Right side of heart is commonly known to be involved and the order of frequency of malignancies to metastasize to layers of the heart is pericardium, myocardium and endocardium.

Entities:  

Keywords:  Endocardium; Left ventricle; Metastasis; Squamous cell carcinoma

Year:  2015        PMID: 28197252      PMCID: PMC5295573          DOI: 10.14740/cr424w

Source DB:  PubMed          Journal:  Cardiol Res        ISSN: 1923-2829


Introduction

Involvement of heart in neoplasm may be primary or secondary. Most common part of heart that is involved in metastases is pericardium. Involvement of endocardium is very rare. Cancers can metastasize to heart by different pathways including lymphatic, hematogenous, transvenous and direct route. Involvement of right side of heart in metastases is common. The most frequent neoplasms that metastasize to heart are melanoma, leukemia and lymphoma. Here we are reporting a case of squamous cell carcinoma of lung that metastasized to left side of heart involving the endocardium near the apical region.

Case Report

A 60-year-old male presented with cough for 6 months associated with decreased appetite and weight loss for the same duration. Cough was non-productive in nature with no history of any diurnal variation. There was no history of hemoptysis and any features suggestive of orthopnoea and PND. He also noticed sequential appearance of nodular swelling in left forearm, nasal tip and scalp. It was insidious in onset. Occasionally the patient had bleeding from nose. The patient had normal bladder and bowel habit. He was non-hypertensive, non-diabetic and had no history of contact with tuberculosis. On examination, higher mental function was within normal limit. Pallor and clubbing was present. Respiratory system revealed bronchial breath sound in right upper lobe. Cardiovascular system, gastrointestinal system and central nervous system examination revealed no abnormality. There was non-fluctuant, non-tender swelling in left forearm, scalp and nose. Laboratory investigations revealed Hb 10.2 gm%, total leukocyte count 11,000/mm3, platelets 1.8 lakhs/mm3, and ESR 70 mm/h. Renal function test and liver function test were within normal limit. Chest X-ray revealed a non-homogenous opacity in right upper lobe. Sputum for acid fast bacilli was negative on two occasions. Sonography of abdomen revealed no abnormality. Echocardiography showed an ejection fraction of 60%. A heterogenous echogenic irregular vascular mass lesion in the endocardium with normal apical mobility suggestive of secondaries in heart was seen (Fig. 1 and 2). Fine needle aspiration cytology from the left forearm mass and scalp swelling showed good cellularity consisting of malignant squamous cells in clusters, sheets and scattered singly in a background of giant cells, cellular debris, necrosis and blood elements suggestive of metastatic squamous cell carcinoma. Contrast-enhanced computerized tomography (CECT) of thorax was carried out along with CT-guided FNAC from the right upper lobe lung mass. Maygrunwald Giemsa staining (Fig. 3A, B) and Pap staining smear showed good cellularity consisting of malignant squamous cells arranged in tightly cohesive clusters and also dispersed singly. Occasional cells show individual cell keratinization. Background revealed many degenerated cells and few cyst macrophages suggestive of squamous cell carcinoma of lung (Fig. 3). The patient was diagnosed as a case of carcinoma of lung with secondaries to heart and multiple sites in skin.
Figure 1

Apical four-chamber view showing heterogenous echogenic irregular vascular mass lesion in the endocardium with normal apical (left ventricular) mobility.

Figure 2

Apical two-chamber view showing heterogenous echogenic irregular vascular mass lesion in the endocardium with normal apical mobility.

Figure 3

Maygrunwald Giemsa staining (A and B) and Pap staining (C and D) of the smears showing good cellularity consisting of malignant squamous cells arranged in tightly cohesive clusters and also dispersed singly. Occasional cells show individual cell keratinization. Background shows many degenerated cells necrosis and few cyst macrophages.

Apical four-chamber view showing heterogenous echogenic irregular vascular mass lesion in the endocardium with normal apical (left ventricular) mobility. Apical two-chamber view showing heterogenous echogenic irregular vascular mass lesion in the endocardium with normal apical mobility. Maygrunwald Giemsa staining (A and B) and Pap staining (C and D) of the smears showing good cellularity consisting of malignant squamous cells arranged in tightly cohesive clusters and also dispersed singly. Occasional cells show individual cell keratinization. Background shows many degenerated cells necrosis and few cyst macrophages.

Discussion

Cardiac metastases usually occur in the sixth to seventh decade of life with no sex preference. Usually the diagnosis is made post-mortem. Most common malignancies that metastasize to heart are malignant melanoma, leukemia and lymphoma. However, the relative numbers are greater with breast and lung cancers [1]. Metastasis to heart is usually infrequent due to reasons like strong action of myocardium, rapid blood flow through the heart, metabolic peculiarities of striated muscle and lymphatic flow that is moving away from heart [2]. Usually it is the right side of the heart that is commonly involved during metastases than the left [3]. Morphologically, it is the pericardium that is most commonly involved in cancer compared to endocardium and myocardium. Neoplasms usually metastasize to heart by means of lymphatic, hematogenous route and direct extension, transvenous extension via the superior or inferior vena cava. Pericardial involvement usually involves lymphatic route and myocardial involvement involves hematogenous route. Endocardial involvement is rare. Metastasis to the heart is also seen quite often in adenocarcinoma of colon [4]. Carcinoma lung, which develops near heart, normally spreads to the heart via two mechanisms, either intracavitary diffusion via the pulmonary veins or direct extension preferentially involving the pericardium leading to pericardial effusion and other complications. Histopathologically, adenocarcinoma of lung spreading to lung has been documented [5]. Neoplasms that have metastasized to the heart are usually asymptomatic [6]. Retrospectively, only about one-tenth of patients who died of cancer and showed cardiac spread as identified at post mortem examination presented with symptoms or had findings indicative of cardiac involvement [7]. Clinical features are usually related to that of the disseminated organ involvement. Cardiovascular signs and symptoms include tachycardia, arrhythmia, cardiomegaly, heart failure, hypotension, dyspnoea, and peripheral cyanosis. The method of choice to detect cardiac metastases and their related complications is two-dimensional echocardiography [8]. Diagnosis of cardiac metastases can also be done through imaging techniques, i.e., CT or magnetic resonance imaging (MRI) [9]. Cardiac metastases are often incurable, so palliative therapy is offered. Systemic chemotherapy is usually the most beneficial. In our case, the primary tumor was squamous cell carcinoma of lung that metastasized to left side of the heart involving the endocardium in the apical region, clinically having tachycardia with no other cardiac manifestations, diagnosed echocardiographically which later was treated with palliative therapy.
  9 in total

1.  Incidence and clinical manifestations of cardiac metastases.

Authors:  H F BISEL; F WROBLEWSKI; J S LADUE
Journal:  J Am Med Assoc       Date:  1953-10-24

Review 2.  Metastases to the heart.

Authors:  K Reynen; U Köckeritz; R H Strasser
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

3.  Cardiac metastasis of a gastric adenocarcinoma.

Authors:  Peter Bernhardt; Almut Jones; Johannes Kaufmann; Vinzenz Hombach; Jochen Spiess
Journal:  Eur Heart J       Date:  2009-05-19       Impact factor: 29.983

4.  Tumors of the heart; review of the subject and report of 150 cases.

Authors:  R W PRICHARD
Journal:  AMA Arch Pathol       Date:  1951-01

5.  Metastatic tumors of the heart detected by two-dimensional echocardiography.

Authors:  S P Kutalek; I P Panidis; M N Kotler; G S Mintz; J Carver; J J Ross
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

6.  Right ventricular tumor in a patient with melanoma.

Authors:  Vinícius Daudt Morais; Flávio Dalbem; Krás Borges; Vicente Restelli
Journal:  Arq Bras Cardiol       Date:  2008-09       Impact factor: 2.000

7.  Cardiac metastasis from colorectal cancer: a case report.

Authors:  Pyong Wha Choi; Chul Nam Kim; Sun Hee Chang; Woo Ik Chang; Chang Young Kim; Hyun Min Choi
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

Review 8.  Heart and tumors: location, metastasis, clinical manifestations, diagnostic approaches and therapeutic considerations.

Authors:  Konstantinos A Ekmektzoglou; Georgios F Samelis; Theodoros Xanthos
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-08       Impact factor: 2.160

9.  Tumor thrombus in right atrium from lung adenocarcinoma.

Authors:  Clara Alexandrescu; Fillipo Civaia; Vincent Dor
Journal:  Ann Thorac Surg       Date:  2009-02       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.